Presynaptic dopaminergic pathology in Chediak-Higashi syndrome with parkinsonian syndrome

Neurology. 2005 May 24;64(10):1814-5. doi: 10.1212/01.WNL.0000162025.31113.0C.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiparkinson Agents / therapeutic use
  • Chediak-Higashi Syndrome / complications
  • Chediak-Higashi Syndrome / diagnostic imaging*
  • Chediak-Higashi Syndrome / physiopathology*
  • Dopamine / metabolism*
  • Humans
  • Leukocytes / enzymology
  • Leukocytes / pathology
  • Male
  • Neostriatum / diagnostic imaging*
  • Neostriatum / physiopathology
  • Neural Pathways / physiopathology
  • Parkinsonian Disorders / complications
  • Parkinsonian Disorders / diagnostic imaging*
  • Parkinsonian Disorders / physiopathology
  • Presynaptic Terminals / diagnostic imaging
  • Presynaptic Terminals / metabolism
  • Presynaptic Terminals / pathology
  • Substantia Nigra / diagnostic imaging*
  • Substantia Nigra / physiopathology
  • Synaptic Transmission / genetics
  • Tomography, Emission-Computed, Single-Photon
  • Treatment Outcome

Substances

  • Antiparkinson Agents
  • Dopamine